Trial Profile
An Open-label One-sequence Cross-over Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir 500/200 mg With Single-dose Valaciclovir (500 mg) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Ritonavir; Valaciclovir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 09 Sep 2014 New trial record